Trial
NCT01531387
Sparing Conversion to Abnormal TCD (Transcranial Doppler) Elevation (SCATE)
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Children's Hospital Medical Center, Cincinnati
Collaborators
National Heart, Lung, and Blood Institute (NHLBI); St. Jude Children's Research Hospital; Tropical Medicine Research Institute; Instituto Estadual de Hematologia Arthur de Siqueira Cavalcanti
Condition
Sickle Cell Anemia
Intervention
Hydroxyurea
Why stopped
inability to reach a satisfactory endpoint with respect to adequate recruitment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-02-08